Codiak BioSciences, Inc. CDAK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:27 AM EDT
0.78quote price arrow down-0.00 (-0.53%)
Volume
3,321
Close
0.7852quote price arrow down-0.0338 (-4.127%)
Volume
155,671
52 week range
0.75 - 17.30
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7852
  • 52 Week High17.30
  • 52 Week High Date09/28/21
  • 52 Week Low0.75
  • 52 Week Low Date09/22/22

Key Stats

  • Market Cap28.27M
  • Shares Out36.00M
  • 10 Day Average Volume0.49M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-92.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.7852
  • 52 Week High17.30
  • 52 Week High Date09/28/21
  • 52 Week Low0.75
  • 52 Week Low Date09/22/22
  • Market Cap28.27M
  • Shares Out36.00M
  • 10 Day Average Volume0.49M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-92.95

RATIOS/PROFITABILITY

  • EPS (TTM)-0.89
  • P/E (TTM)-0.89
  • Fwd P/E (NTM)-0.33
  • EBITDA (TTM)-48.694M
  • ROE (TTM)-41.23%
  • Revenue (TTM)34.70M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-57.18%
  • Debt To Equity (MRQ)57.65%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Codiak BioSciences, Inc.

 

Profile

MORE
Codiak BioSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of exosome-based therapeutics. The Company has developed its engineering and manufacturing platform, engEx Platform, to develop upon the innate properties of exosomes to design, engineer and manufacture exosome therapeutics. It utilizes the engEx Platform to generate a pipeline of engineered exosomes (engEx) exosomes, focused at treating a range of diseases...
Steven Gillis Ph.D.
Independent Chairman of the Board
Douglas Williams Ph.D.
President, Chief Executive Officer, Director
Linda Bain
Chief Financial Officer, Treasurer
Konstantin Konstantinov Ph.D.
Chief Technology Officer
Yalonda Howze J.D.
Executive Vice President, Chief Legal and Compliance Officer, Corporate Secretary
Address
35 CambridgePark Drive, Suite 500
Cambridge, MA
02140
United States

Top Peers

SYMBOLLASTCHG%CHG
MTEM
Molecular Templates Inc
0.653-0.0141-2.1136%
ANGN
Angion Biomedica Corp
0.9216+0.0116+1.27%
ORGS
Orgenesis Inc
1.40-0.02-1.41%
OBSV
Obseva SA
0.1402-0.0027-1.8894%
BTX
Brooklyn Immunotherapeutics Inc
0.2289+0.0094+4.28%